A UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer’s disease. The results show the inhibition of the enzyme soluble epoxide hydrolase
The COVID-19 pandemic caused by the new coronavirus has created an unprecedented public health challenge globally. Little was known about how the infecting cells respond to the virus
Ultraviolet light has been used to stop pathogens in their tracks for decades. But does it work against SARS-CoV-2, the virus behind the pandemic? The short answer is
Many heritable immune diseases such as rheumatoid arthritis and blood-cell related traits derive from critical proteins not being made or not functioning correctly. But exactly how a person’s
Since its introduction in 2011, functional ultrasound (fUS) imaging is progressively rising as a predominant neuroimaging modality. From this technique, developed by the team of Mickael Tanter (laboratory
New muscle has successfully been created in mice using a minimally invasive technique dubbed “intravital 3-D bioprinting” by a team involving UCL scientists. This new research could pave
If you’re like many people who are basically quarantine cooking rock stars these days, you’re probably perusing more cookbooks than take-out menus. And maybe — just maybe —
Professors in Texas Tech University’s Department of Mechanical Engineering through the Edward E. Whitacre Jr. College of Engineering have developed a new epidemiological model for predicting COVID-19 spread
During the next year, the Food and Drug Administration will review many new drug applications for preventing and treating the new coronavirus. But early approvals could get delayed
In recent decades, under the harmful influence of western lifestyles, the diversity of the microbial colonization of the body has decreased significantly. This ‘impoverished’ microbiome has led to
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
